more_reports

The Latest Regenerative Medicine Articles from Streetwise Reports

Regenerative Medicine Co. Adds Saudi Arabia Diabetes Initiative

  ()
Leading regenerative medicine company Sernova Corp. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) announces agreement to explore fighting type I diabetes in Saudi Arabia. Read why one analyst believes the company's technology is "advanced."
Tags: Regenerative MedicineBiotechnology / Pharmaceuticals

Two Firms Aim To Create Functional Cure for Type 1 Diabetes

  ()
Each company is pursuing its own treatment approach to achieve insulin independence, consisting of islet cells (donor or stem cell derived), delivered into the portal vein or housed in a Cell Pouch bio-hybrid organ that is implanted in the body. Learn more about their respective programs.
Tags: Medical DevicesRegenerative Medicine

New Blood Cancer Treatment Shows Continued Response

Research Report
  ()
The biotech behind this cell therapy has numerous near-term catalysts related to its pipeline, noted a Wedbush report.
Tags: Regenerative Medicine

Regenerative Med Co. Granted Second Tissue License

Research Report
  ()
With these expanded capabilities, the biotech may increase revenue generation and continue its clinical trial, noted a Roth MKM report.
Tags: Regenerative Medicine

Regenerative Medicine Co. May Have Solution to Delivering Cell Treatments

  ()
This Canadian life sciences firm is developing an implantable cell-containing pouch, shown in clinical trial data thus far to be safe, well-tolerated and effective. Learn why several analysts rate the company Buy.
Tags: Regenerative MedicineMedical Devices

Showing Results: 1 to 5 of 5